The role of some biochemical markers in the pathogenesis of diabetic nephropathy

View at publisher
Authors: Daroon Essam Raffik, Amina Hamed Ahmed, Abdullah Adil Raoof
Cited by: 0
References: 21

Abstract

One of the main causes of end-stage renal disease worldwide is diabetic nephropathy (DN). For prompt intervention and better patient outcomes, early detection of biochemical markers linked to DN pathogenesis is essential. Objectives: the pathophysiology of diabetic nephropathy was examined in relation to inflammatory indicators (C-reactive protein [CRP], tumor necrosis factor-alpha [TNF-α]), α-Klotho, and glycemic control markers (glycated hemoglobin [HbA1c], glycated albumin, and ractopamines). Methods: Between October 2024 and April 2025, a six-month cross-sectional study was carried out at Azadi Teaching Hospital and Kirkuk Teaching Hospital. 360 individuals were carefully split into four groups for the study: 90 patients with diabetes who did not have nephropathy, 90 patients with chronic renal disease (CRD), 90 patients with diabetic nephropathy, and 90 healthy controls. Standardized laboratory procedures were used to analyze biochemical parameters. Analysis of variance (ANOVA), post-hoc testing, correlation analysis, and multivariate regression analysis were all included in the statistical analysis. TNF-α concentrations (204.13±86.17 pg/mL vs. 32.28±13.97 pg/mL, p

Fields of Study & Subjects

Chronic Kidney Disease and Diabetes Advanced Glycation End Products research Renal Diseases and Glomerulopathies

Publication details

Journal / source
AIP conference proceedings
Volume
3486
Pages
780001–780001
Publication date
1 January 2026
Language
EN